Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 February 2025 | Story Lacea Loader
University of the Free State Logo

On 12 February 2025, disruption of academic activities occurred on the Bloemfontein Campus of the University of the Free State (UFS); this followed the disruptions that occurred on 11 February 2025. On the Qwaqwa Campus, attempts to disrupt academic activities also occurred on 12 February 2024.

A memorandum of demands from the Institutional Student Representative Council (ISRC) was handed over to the university management on 11 February 2025, to which management responded; these demands are related to registration and funding. 

Financial concessions have been granted to students on two occasions so far this year to enable them to register. On 10 February 2025, the university granted follow-up concessions.

Furthermore, the institution’s Financial Working Group (FWG) – which includes representatives from the Institutional Student Representative Council (ISRC) – met regularly to determine how it could best assist students to register, taking into consideration the financial constraints of the university.

On the Bloemfontein Campus, 15 students were arrested on 12 February 2025 for transgression of the interdict; internal disciplinary processes are being instituted.

The university’s Protection Services has activated its protest management security escalation plan in accordance with the UFS Protest Management Policy; the situation on the campuses is being closely monitored.

All classes are continuing as normal, and no classes have been suspended. 

It is important to note the NSFAS-related progress made up until now: 

  • NSFAS funding has been confirmed and allocated to 25 551 students.
  • 22 246 of these students have already been successfully registered for the academic year.
  • NSFAS allowances were paid to 14 303 registered students on 3 February 2025.
  • On 17 February 2025, interim allowances will be paid to 7 943 students who were not registered at the time of the first round of payments.
Financial concessions have been granted to students during two occasions so far this year. On 10 February 2025, the university granted the following follow-up concessions: 

1. NSFAS-funded students

Criteria:

  • NSFAS funding for 2025 must be confirmed and reflected on the acknowledgement of debt (AOD) or registration verification document.
  • Historic debt may not exceed R35 000.

Concessions:

  • No payment is required.
  • Students will be eligible for full registration.

Criteria: 

  • NSFAS funding for 2025 must be confirmed and reflected on the acknowledgement of debt (AOD) or registration verification document.
  • Historic debt exceeding R35 000 but not exceeding R50 000.
      Concessions:
  • No payment is required.
  • Students will be eligible for provisional registration. Provisional registration applications must be submitted, and all other terms and conditions will apply.
2. Returning self-paying South African students:

Criteria:
  • Historic debt must not exceed R35 000.
  • Must sign an acknowledgment of debt (AOD).
Concessions:
  • No payment is required.
  • Students will be eligible for provisional registration. Provisional registration applications must be submitted, and all other terms and conditions will apply.
3. Final-year students:
  • Students with an average mark of above 60% were assisted with Monitoring bursaries.
  • 2025 final-year students with an average mark of between 50% and 60% will be assisted with the following concessions.  
Criteria:
  • Final-year students with a pass rate of between 50 and 60% and with outstanding fees up to a maximum of R60 000 to register provisionally.
Concessions:
  • No payment is required.
  • Students must complete a provisional registration application and attach an AOD, covering historic debt plus the first payment required for 2025 registration. 
4. Postgraduate students 
  • The Department of Finance is in contact with the Centre for Postgraduate Support to fast-track funding confirmations.
  • Postgraduate students who have studied at other institutions and wish to register at the UFS must contact Student Finance for possible assistance with registration.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept